Fig. 5.
A second metalloprotease inhibitor, BB-94, has effects similar to those of GM6001 on RGC axon guidance and extension.A–D, HRP-labeled optic projections in stage 40 whole-mount brains exposed at stage 33/34 to 0.1 μm(A) and 1.0 μm(B–D) BB-94. At the low dose of BB-94 (A) the optic projection forms normally. At 1.0 μm, BB-94 RGC axons do not turn in the mid-diencephalon (B, C) and fail to innervate the optic tectum (D). D is a higher-power view ofC. The dotted white line shows the approximate anterior border of the optic tectum. Tec, Tectum; Pi, pineal gland; D, dorsal;V, ventral. Scale bars: C (forA–C), D, 50 μm.